Frontlight ResearchEarly access
Bladder cancer trials in Romania
4 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 4Not yet taking people in RomaniaA Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
- Where
- Brasov, Bucharest
- Age
- 18 years and over
- People
- 33 worldwide
- Run by
- Urogen Pharma Ltd.
See details and how to join2026-526359-75-00 - Phase 3CompletedRoll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Suceava
- Age
- 18 years and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00 - Phase 3Taking peopleA Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Where
- Bucharest, Cluj-Napoca, Iași, Oradea, Timișoara
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- UroGen Pharma Ltd.
See details and how to joinNCT06774131 · EU 2024-519343-15-00 - Phase 2/3Taking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Cluj-Napoca, Craiova, Iași
- Age
- 18 years and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762